Entering text into the input field will update the search result below

Guardant Health to end four-day selloff on Medicare Coverage for tissue-based cancer test

Mar. 08, 2022 3:33 PM ETGuardant Health, Inc. (GH)By: Dulan Lokuwithana, SA News Editor1 Comment

Stethoscope with medicare form with parts list.

designer491/iStock via Getty Images

  • Guardant Health (GH +5.1%) is set to close higher for the first time in four sessions on Tuesday after the precision oncology company announced a favorable decision on Medicare coverage for its Guardant360 TissueNext test.

Recommended For You

Comments (1)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

LRNMO25 profile picture
This is a winner at todays sp.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.